Pfizer has reached a $44 million class action settlement over contamination issues with its Chantix smoking cessation drug. Eligible buyers who purchased the medication at retail may qualify with proof of purchase. The post Pfizer Preparing To Send $44,000,000 to Settle Allegations That Prescription Drug Contained Carcinogen appeared first on The Daily Hodl .